Previous studies demonstrated that mutations in PIK3CA cause gain-of-function of PI3K, which leads to activation of downstream pathways and enhances cellular growth in cancer and a spectrum of overgrowth disorders [5, 19–21]. This evidence concerns the gene PIK3CG and cancer.